In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Symrise restructuring

This article was originally published in The Rose Sheet

Executive Summary

Strategic realignment will result in elimination of 420-500 jobs worldwide, including positions in firm's Holzminden, Germany headquarters, Symrise announces June 22. Restructuring could produce additional cuts in the future, company adds. Flavors and fragrance supplier also is considering moving production facilities in Germany and North America to lower-wage countries. Realignment is aimed at further standardizing processes in all regions to increase consistency and efficiency, according to the firm, and changes to administrative and production divisions already have resulted in improvements in the past year. Symrise was formed in 2003 through a merger of Haarmann & Reimer and Dragoco...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel